Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Mona is a registered dietitian-nutritionist (RDN) and multiple sclerosis certified specialist (MSCS) who has been living with relapsing multiple sclerosis (MS) herself since 2008. She gets it.

Experts aren’t sure what causes multiple sclerosis, but they have identified four primary risk factors that may interact with each other: immune system malfunction, genetics, environmental ...

Targeting Myelin Damage in Multiple Sclerosis and Age-Related Decline The drug, LL-341070, enhances the brain's ability to repair damaged myelin— the protective sheath around nerve fibers.

An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in mice, the biotech announced Dec. 23. The Texas-based company conducted ...

Researchers identified a unique antibody signature against the Epstein-Barr virus protein EBNA1 that correlates with cross-reactive immune responses in multiple sclerosis (MS) patients.

In multiple sclerosis (MS), macrophages and microglia play a dual role that could be used to treat this neurodegenerative disease. These cells promote inflammation that demyelinates neurons but also ...

News Release 30-Jun-2023 Multiple sclerosis: Myelin may be detrimental to nerve fibres Studies provide new insight into the mechanisms of the disease Peer-Reviewed Publication Universität Leipzig ...

This important study combined MRI (magnetic resonance imaging) imaging and histopathology to examine the remyelination of brain lesions in an EAE marmoset model of multiple sclerosis. This work ...